GHRH
GHRH, or Growth Hormone-Releasing Hormone, is your brain’s master signal that tells your pituitary gland to make and release growth hormone in healthy, pulsatile patterns that mirror youthful sleep cycles. Produced naturally in a small brain region called the hypothalamus, it controls far more than just muscle growth—GHRH also regulates metabolism, bone density, immune function, sleep quality, and cognitive sharpness.
Route
Subcutaneous injection
Dose range
100 mcg – 200 mcg
Frequency
Once daily
Cycle length
12 weeks
Overview
GHRH, or Growth Hormone-Releasing Hormone, is your brain’s master signal that tells your pituitary gland to make and release growth hormone in healthy, pulsatile patterns that mirror youthful sleep cycles. Produced naturally in a small brain region called the hypothalamus, it controls far more than just muscle growth—GHRH also regulates metabolism, bone density, immune function, sleep quality, and cognitive sharpness. As you age, GHRH production declines, explaining the slower recovery, weaker muscles, and poorer sleep that creeps in after 30, even in healthy people.
Synthetic GHRH (called somatorelin in pharmaceutical form) works by restoring youthful GH pulses, providing benefits in muscle gain, fat loss, bone strengthening, and cognitive enhancement. Research shows it’s especially useful for GH deficiency and childhood growth disorders, but increasingly recognized for anti-aging and athletic performance. Combined with other peptides like GHRP-2 or GHRP-6, it creates dramatic synergy by amplifying natural GH release pathways. Users report improved sleep architecture, sustained energy, faster workout recovery, and metabolic improvements. For athletes or aging adults seeking to restore youthful hormone patterns naturally, GHRH offers a foundational approach to regenerating the growth hormone axis that declines with time.
Studied benefits
- Stimulates the pituitary gland to produce and release natural Growth Hormone
- It supports the maintenance of lean muscle, bone density, and metabolic efficiency while following the body's natural circadian rhythm
Reported side effects
- May cause temporary flushing, mild water retention, or tingling in the extremities
- Long-term use generally maintains a high safety profile when used correctly
Protocol
Dosing Schedule (Subcutaneous)
Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.
| Tier | Dose (mcg) | Draw at 2.5 mg/mL | Log |
|---|---|---|---|
| Diagnostic/Initial | 100 mcg | 4 units (0.04 mL) | + Log |
| Enhanced Research | 200 mcg | 8 units (0.08 mL) | + Log |
Frequency
Once daily.
Timing
Bedtime on an empty stomach.
Cycle length
12 weeks.
Unit calculator
Set your vial and water; the table above updates.
2.5 mg/mL
50 doses of 100 mcg per vial
At the starting dose (100 mcg × 7/week for a 12-week cycle) you would use about 8.4 mg, i.e. 2 × 5 mg vials. Higher phases use proportionally more.
Assumes a U-100 insulin syringe (100 units = 1 mL). Educational math only; verify every calculation yourself.
Context
Lifestyle considerations
Maintain a high-protein, balanced diet to provide the building blocks for the increased protein synthesis associated with elevated growth hormone levels. Incorporate regular physical exercise, particularly resistance training, to stimulate the natural release of GHRH and maximize the anabolic benefits of the protocol. Ensure 7–9 hours of quality sleep, as Growth Hormone Releasing Hormone acts most effectively on the pituitary during deep sleep cycles. Practice intermittent fasting or avoid eating late at night to ensure that somatostatin levels are low, allowing for higher-amplitude GH pulses.
Evidence
Research summaries
Agonists of growth hormone-releasing hormone (GHRH) receptor inhibit experimental lung cancer developed in nude mice and show synergism with radiation
Findings: Fights lung cancer growth, protects heart muscle, helps diabetes eye issues, speeds wound healing.
Special GHRH versions (like MR409) act on cancer cells to slow them down in lab dishes and mouse tumors. But in live animals, they shrank lung cancers and worked extra good with radiation. Beyond cancer, they saved heart cells after heart attacks in rats, cut scar tissue in pigs, and shrunk big hearts in mice. For diabetes, they helped eye repair and kept new pancreas cells alive after transplants. They also sped skin healing and stopped artery hardening. This means GHRH helpers aren't just for growth – they repair hearts, eyes, and wounds while fighting tumors. Cool for sick hearts or cancer without messing GH too much.
Read the study ↗Growth hormone-releasing hormone receptor (GHRH-R) and its cognates in health and disease
Findings: Boosts pancreas cells for diabetes fix, repairs heart after damage, stops some cancers growing.
GHRH hooks to a brain receiver to pump out GH for growth. But new fake versions grow pancreas cells, help sugar control in diabetes rats, and make islet transplants stick better. For hearts, they boost pump strength, shrink dead spots post-heart attack, and calm over-big hearts. Cancer side: blockers of GHRH stop prostate, stomach, eye, and skin cancers in tests. No small pills yet, but peptides show promise. This opens doors for diabetes cures, heart fixes, and cancer blocks. It's like GHRH has secret powers for fixing adult body parts beyond just height.
Read the study ↗Growth hormone-releasing hormone signaling and cardioprotection: from bench to bedside
Findings: Makes heart beat stronger, cuts swelling and stress, fixes damage in different heart sicknesses.
GHRH signals help hearts without always raising GH a ton. In rat, pig, and mouse tests for heart attacks, weak pumps, or big hearts, it boosted squeeze power, cut scar size, and eased swelling. It fights bad stress chemicals and fixes twisted heart shapes. Challenges: how to give it (pills? shots?) and watch GH side effects. Still, animal wins scream "try in people!" for heart fixes. Think of it as a heart trainer making muscles tougher against age or injury.
Read the study ↗Effect of GHRH and GHRP-2 treatment in vitro on GH, pituitary hormones, and cell morphology in ovine pituitary cell cultures
Findings: Pumps up GH levels fast, changes brain signals for better hormone balance.
In sheep brain cell dishes, GHRH and a buddy (GHRP-2) jacked GH messages and release in hours. They upped receivers for GH signals and a boss gene (Pit-1), but tweaked calm-down signals (sst). This explains why they team up for big GH bursts. For kids or adults low on GH, it means targeted boosts without overload. Simple: GHRH wakes the GH factory directly.
Read the study ↗Identification
Chemistry
- cas
- 9034-39-3 (native GHRH); 83930-13-6 (somatorelin, full 44-amino acid form); 86168-78-7 (sermorelin, GRF 1-29 amide)
- formula
- C₂₁₅H₃₅₈N₇₂O₆₆S (full 44-amino acid GHRH); C₁₄₉H₂₄₆N₄₄O₄₂S (sermorelin/GRF 1-29)
- molecular weight
- 5040 g/mol (full 44-amino acid GHRH/somatorelin); 3357.9 g/mol (sermorelin/GRF 1-29 amide)
- sequence
- H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-OH (full 44-amino acid form); first 29 amino acids constitute the biologically active core (GHRH 1-29)
- source
- Natural; synthesized in the arcuate nucleus of the hypothalamus
- biosynthesis
- Ribosomal; translated from mRNA in hypothalamic neurons; undergoes proteolytic processing to generate mature hormone
- type
- Linear peptide; amidated C-terminus in pharmaceutical preparations
Keep exploring
Related peptides
CJC-1295 (No DAC)
No DAC
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 8–12 weeks
CJC-1295 (No DAC), GHRP-2
No DAC · CJC-1295 (No DAC)
- Route
- Subcutaneous
- Dose
- 100 mcg – 200 mcg
- Cycle
- 12–16 weeks
CJC-1295 (No DAC), GHRP-6
No DAC · CJC-1295 (No DAC)
- Route
- Subcutaneous
- Dose
- 100 mcg – 150 mcg
- Cycle
- 8–12 weeks
CJC-1295 (no DAC), Hexarelin
no DAC · CJC-1295 (No DAC)
- Route
- Subcutaneous
- Dose
- 100 mcg – 200 mcg
- Cycle
- 4–6 weeks (shorter cycles prevent receptor desensitization)